The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Nucleic Acid Amplification Testing Market During 2026–2030?
The nucleic acid amplification testing market size has shown substantial growth in recent years. This market is set to increase from $11.03 billion in 2025 to $12.7 billion in 2026, with a compound annual growth rate (CAGR) of 15.2%. The expansion witnessed historically can be linked to factors such as infectious disease outbreaks, the proliferation of clinical laboratories, the widespread adoption of PCR technology, various public health screening initiatives, and a decrease in assay costs.
The nucleic acid amplification testing market is forecast to undergo significant expansion in the next few years. It is predicted to reach $22.1 billion in 2030, with a compound annual growth rate (CAGR) of 14.8%. This growth during the forecast period is expected to be driven by the rise of personalized medicine, increasing demand for rapid diagnostics, an expanding presence in emerging markets, technological miniaturization, and regulatory approvals for innovative assays. Noteworthy trends anticipated in this period include the proliferation of rapid point-of-care molecular testing, the enlargement of multiplex and syndromic panels, the increasing adoption of isothermal amplification techniques, a surge in home-based and decentralized testing, and a stronger focus on early disease detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp
What Underlying Factors Are Accelerating The Growth Of The Nucleic Acid Amplification Testing Market?
The rising occurrence of infectious diseases is anticipated to drive expansion in the nucleic acid amplification testing market in the future. Infectious diseases are health conditions stemming from organisms capable of spreading between individuals, either directly or indirectly, through diverse channels like physical touch, airborne dispersal, tainted food or water, or transmission by vectors such as insects. This surge in infectious diseases is attributed to factors including antibiotic resistance, shifts in climate, alterations in human conduct, and agricultural methods. Nucleic acid amplification testing (NAAT) quickly and precisely identifies infectious pathogens, enabling prompt diagnosis and treatment, which in turn aids in managing disease transmission. As reported in October 2023 by the Public Health Agency of Canada, a government agency based in Canada, the 2022–2023 season saw 4,216 influenza-related hospitalizations across participating provinces and territories. Consequently, the growing frequency of infectious diseases is a key factor propelling the expansion of the nucleic acid amplification testing market.
How Are The Various Segments Of The Nucleic Acid Amplification Testing Market Categorized?
The nucleic acid amplification testing market covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Amplification Method: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
What Trends Are Affecting The Expansion Of The Nucleic Acid Amplification Testing Market?
Major companies operating in the nucleic acid amplification testing market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for CMV by nucleic acid amplification technology (NAT) under the IVDR. An IVD (in vitro diagnostic) assay involves a test performed on biological samples to detect diseases, conditions, or infections outside the body within a laboratory setting. For instance, in June 2024, GFE, a Germany-based company, launched the PoET CMV. PoET CMV, an IVD assay, is specifically designed for the rapid and precise detection of cytomegalovirus (CMV) infections. Its distinct attributes include high sensitivity and specificity, enabling early diagnosis and effective monitoring of CMV in transplant patients and immunocompromised individuals. The assay leverages advanced molecular techniques to deliver reliable results quickly, thus supporting timely clinical decision-making.
Which Major Firms Influence Developments In The Nucleic Acid Amplification Testing Market?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
Read the full nucleic acid amplification testing market report here:
Which Region Is Projected To Dominate The Nucleic Acid Amplification Testing Market During The Forecast Period?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Nucleic Acid Amplification Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19619&type=smp
Browse Through More Reports Similar to the Global Nucleic Acid Amplification Testing Market 2026, By The Business Research Company
Nucleic Acid Based Gene Therapy Market Report 2026
Nucleic Acid Isolation And Purification Market Report 2026
Automated Nucleic Acid Extraction Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model